These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Dependence on LSD and other hallucinogenic drugs. JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003 [No Abstract] [Full Text] [Related]
44. Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Hyde C; Glancy G; Omerod P; Hall D; Taylor GS Br J Psychiatry; 1978 Jun; 132():602-4. PubMed ID: 566144 [TBL] [Abstract][Full Text] [Related]
45. Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature. Honyiglo E; Franchi A; Cartiser N; Bottinelli C; Advenier AS; Bévalot F; Fanton L J Forensic Sci; 2019 Jul; 64(4):1266-1270. PubMed ID: 30548541 [TBL] [Abstract][Full Text] [Related]
46. [The toxicological aspects of poisonings by psilocybine-containing mushrooms]. Babakhanian RV; Bushuev ES; Kazankov SP; Kostyrko TA Sud Med Ekspert; 1997; 40(3):20-2. PubMed ID: 9304247 [TBL] [Abstract][Full Text] [Related]
47. The rising price of mushrooms. Young RE; Milroy R; Hutchison S; Kesson CM Lancet; 1982 Jan; 1(8265):213-5. PubMed ID: 6119567 [No Abstract] [Full Text] [Related]
48. Harm potential of magic mushroom use: a review. van Amsterdam J; Opperhuizen A; van den Brink W Regul Toxicol Pharmacol; 2011 Apr; 59(3):423-9. PubMed ID: 21256914 [TBL] [Abstract][Full Text] [Related]
49. Liberty caps: recreational hallucinogenic mushrooms. Pollock SH Drug Alcohol Depend; 1976 Oct; 1(6):445-7. PubMed ID: 1035156 [No Abstract] [Full Text] [Related]
56. Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Kopra EI; Ferris JA; Winstock AR; Young AH; Rucker JJ J Psychopharmacol; 2022 Aug; 36(8):965-973. PubMed ID: 35388724 [TBL] [Abstract][Full Text] [Related]
57. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556 [TBL] [Abstract][Full Text] [Related]
58. [The evaluation of methods of usage of addictive substances among high school students and Gdańsk University students]. Chodorowski Z; Sein Anand J; Sein Anand I; Salamon M Przegl Lek; 2000; 57(10):549-52. PubMed ID: 11199884 [TBL] [Abstract][Full Text] [Related]
59. Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus. Cuomo MJ; Dyment PG; Gammino VM J Am Coll Health; 1994 May; 42(6):271-4. PubMed ID: 7913938 [TBL] [Abstract][Full Text] [Related]
60. Psychoactive drugs and quality of life. Ventegodt S; Merrick J ScientificWorldJournal; 2003 Aug; 3():694-706. PubMed ID: 12941969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]